Anti-angiogenic gene therapy of ocular vascular diseases
Ended Project Grant Awarded Last action
- Award ID
- R43EY031238
- Recipient
-
Everglades Biopharma LLC UEI Y8MLVKZH8TT3
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,746
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Originally
- Place of performance
- Florida, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$254 | |
| Original award | $225,000 |
Quick answers
Who received award R43EY031238?
R43EY031238 was awarded to Everglades Biopharma LLC by National Eye Institute (National Institutes of Health) on July 1, 2020.
How much is award R43EY031238 worth?
$224,746 has been obligated on R43EY031238.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award